Therapeutic plasma exchange decreases levels of routinely used cardiac and inflammatory biomarkers

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Tutarel, Oktay ^a   Golla, Paulina ^a   Beutel, Gernot ^a   Bauersachs, Johann ^a   David, Sascha ^a   Schmidt, Bernhard M W ^a   Lichtinghagen, Ralf ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; TROPONIN T;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; MALE; PLASMAPHERESIS; PROTEIN BLOOD LEVEL; THERAPY EFFECT;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HEART DISEASES; HUMANS; INFLAMMATION; KINETICS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PLASMA EXCHANGE; PROTEIN PRECURSORS; TIME FACTORS; TROPONIN T;

EID: 84862025145     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038573     Document Type: Article

References (14)

1. Abel JL, Rowntree LG, Turner BB, (1914) Plasma removal with return of corpuscles (plasmaphaeresis). J Pharmacol Exp Ther 5: 625-641.
2. Ward DM, (2011) Conventional apheresis therapies: a review. J Clin Apher 26: 230-238.
3. Okafor C, Ward DM, Mokrzycki MH, Weinstein R, Clark P, et al. (2010) Introduction and overview of therapeutic apheresis. J Clin Apher 25: 240-249.
4. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, et al. (2010) Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 25: 83-177.
5. Registry GE-H, (2011) The German 2011 epidemic of Shiga toxin-producing E. Coli - the nephrological view. Nephrol Dial Transplant 26: 2723-2726.
6. Patschan D, Witzke O, Duhrsen U, Erbel R, Philipp T, et al. (2006) Acute myocardial infarction in thrombotic microangiopathies - clinical characteristics, risk factors and outcome. Nephrol Dial Transplant 21: 1549-1554.
7. Dengler TJ, Zimmermann R, Braun K, Muller-Bardorff M, Zehelein J, et al. (1998) Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation. J Am Coll Cardiol 32: 405-412.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29: 2388-2442.
9. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, et al. (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J.
10. Hershcovici T, Schechner V, Orlin J, Harell D, Beigel Y, (2004) Effect of different LDL-apheresis methods on parameters involved in atherosclerosis. J Clin Apher 19: 90-97.
11. Bektas M, Idilman R, Soykan I, Soydan E, Arat M, et al. (2008) Adjuvant therapeutic plasma exchange in liver failure: assessments of clinical and laboratory parameters. J Clin Gastroenterol 42: 517-521.
12. Morath C, Sis J, Haensch GM, Zeier M, Andrassy K, et al. (2007) Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading. Nephrol Dial Transplant 22: 2701-2704.
13. Kittleson MM, Skojec DV, Wittstein IS, Champion HC, Judge DP, et al. (2009) The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. J Heart Lung Transplant 28: 704-709.
14. Grauhan O, Knosalla C, Ewert R, Hummel M, Loebe M, et al. (2001) Plasmapheresis and cyclophosphamide in the treatment of humoral rejection after heart transplantation. J Heart Lung Transplant 20: 316-321.